Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GCN2 (General Control Nonderepressible 2) is a serine/threonine-protein kinase that plays a central role in the cellular response to amino acid deprivation and other forms of metabolic stress. It senses amino acid deficiency by binding to uncharged transfer RNAs (tRNAs), which accumulate when amino acids are scarce. Upon activation, GCN2 phosphorylates the alpha subunit of eukaryotic translation initiation factor 2 (eIF2α) at Ser51. This phosphorylation event represses general protein synthesis but selectively allows translation of specific mRNAs involved in stress adaptation.
Phosphorylation of eIF2α at Ser51, leading to repression of global protein synthesis and selective translation of stress-related mRNAs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic Translation Initiation Factor 2 Alpha Kinase GCN2 (GCN2).